e-Drug3D

941

cas 191732-72-6

CLASS

ANTINEOPLASTIC
THALIDOMIDE ANALOG
POSSESSES IMMUNOMODULATORY, ANTIANGIOGENIC, AND ANTINEOPLASTIC PROPERTIES
TARGET NOT KNOWN
TREATMENT OF MULTIPLE MYELOMA (MM)

ROUTE (list)

ORAL

PK parameters

Tmax 3.25 HOUR
PPB 30 PERCENT
t1/2 3 HOUR

MW 259.26
NB_atoms 19
XLogP 0.03
PSA 92.318
NB_HD 3
NB_HA 6
fsp3 0.31
Lipinski(0=no;1=yes) 1

FDA
NDA 021880 (pdf not found) INN (LENALIDOMIDE) REVLIMID (BRISTOL MYERS SQUIBB) APPROVAL= AP YEAR= 2005
NDA 201452 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (ARROW INTL) APPROVAL= AP YEAR= 2021
NDA 209348 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (DR REDDYS) APPROVAL= AP YEAR= 2021
NDA 210480 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (LOTUS PHARM CO LTD) APPROVAL= AP YEAR= 2022
NDA 210154 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2022
NDA 210435 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (CIPLA) APPROVAL= AP YEAR= 2022
NDA 211022 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (APOTEX) APPROVAL= AP YEAR= 2022
NDA 213912 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (MYLAN) APPROVAL= AP YEAR= 2022
NDA 213885 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (EUGIA PHARMA) APPROVAL= AP YEAR= 2023
NDA 211846 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (SUN PHARM) APPROVAL= AP YEAR= 2023
NDA 212414 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (HETERO LABS LTD V) APPROVAL= AP YEAR= 2023
NDA 213405 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (TORRENT) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 214618 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (CIPLA) APPROVAL= AP YEAR= 2023
NDA 217265 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (QILU) APPROVAL= AP YEAR= 2024 DISCONTINUED
NDA 217281 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (NOVUGEN) APPROVAL= AP YEAR= 2024
NDA 215759 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (BIOCON PHARMA) APPROVAL= AP YEAR= 2025
NDA 216213 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (AMNEAL) APPROVAL= AP YEAR= 2025 DISCONTINUED
NDA 217554 (pdf not found) INN (LENALIDOMIDE) LENALIDOMIDE (DEVA HOLDING AS) APPROVAL= AP YEAR= 2025